937625-32-6

Basic information

• Product Name: Ethyl 4-ethoxy-3-nitrobenzoate
• Synonyms: Ethyl 4-ethoxy-3-nitrobenzoate
• CAS NO: 937625-32-6
• Molecular Formula: C₁₁H₁₃NO₅
• Molecular Weight: 239.22462
• Mol File: 937625-32-6.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Ethyl 4-ethoxy-3-nitrobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 4-ethoxy-3-nitrobenzoate(937625-32-6)
• EPA Substance Registry System: Ethyl 4-ethoxy-3-nitrobenzoate(937625-32-6)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 937625-32-6(Hazardous Substances Data)

Upstream product

• 74-96-4 ethyl bromide 
• 329-59-9 4-fluoro-3-nitro-benzoic acid methyl ester 
• 141-52-6 sodium ethanolate 
• 616-82-0 3-nitro-4-hydroxybenzoic acid 
• 75-03-6 ethyl iodide 

Downstream Products

• 1377582-54-1 2-(4-ethoxy-3-nitro-phenyl)-oxazole 
• 875256-49-8 3-amino-4-ethoxybenzoic acid 
• 1608146-57-1 tert-butyl N-(5-{5-[5-(4-ethoxy-3-methanesulfonamidophenyl)-1,2,4-oxadiazol-3-yl]-1-benzofuran-2-yl}-2,2-dimethyl-1,3-dioxan-5-yl)carbamate 
• 1608146-55-9 N-(2-ethoxy-5-(3-(3-iodo-4-hydroxyphenyl)-1,2,4-oxadiazol-5-yl)phenyl)methanesulfonamide 
• 1608146-53-7 N-(2-ethoxy-5-(3-(3-iodo-4-isopropoxyphenyl)-1,2,4-oxadiazol-5-yl)phenyl)methanesulfonamide 
• 1608146-50-4 4-ethoxy-3-(methylsulfonamido)benzoic acid 
• 1608144-23-5 N-(5-(3-(2-(2-amino-1,3-dihydroxypropan-2-yl)benzofuran-5-yl)-1,2,4-oxadiazol-5-yl)-2-ethoxyphenyl)methanesulfonamide 
• 59719-77-6 4-ethoxy-3-nitrobenzoic acid 
• 175204-17-8 ethyl 4-(acetylamino)-3-nitrobenzoate 
• 41263-74-5 4-(methylamino)-3-nitrobenzoic acid 
• 41263-65-4 4-amino-3-nitrobenzamide 
• 1588-83-6 4-amino-3-nitrobenzoic acid 
• 76918-64-4 ethyl 4-amino-3-nitrobenzoate 

Relevant articles and documents

ORGANIC COMPOUNDS

Novel benzofuran derivatives are disclosed. The derivatives have S1P1 receptor activity and/or disease modifying activity and find use in the treatment of conditions or diseases associated with the immune, vascular and nervous systems in animals and/or humans

BISTHIAZOLE INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION

This invention relates to bisthiazole I and its therapeutic and prophylactic uses, wherein the variables A, R5, R6, and R7 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.